Markets

Above Food Ingredients Shares Surge 22% Amid Delayed Filing

Above Food Ingredients shares soared 22% to $0.65 in heavy trading Monday, as the company's fiscal 2025 annual report remains delayed due to ongoing audit issues.

Daniel Marsh · · 2 min read · 0 views
Above Food Ingredients Shares Surge 22% Amid Delayed Filing
Mentioned in this article
ABVE $0.53 -2.47%

Above Food Ingredients Inc. saw its stock price surge approximately 22% on Monday, reaching $0.65 per share, as trading volume exploded to over 42 million shares. The rally came despite the company's ongoing struggle to file its fiscal 2025 annual report, which remains delayed due to an unresolved audit.

The stock traded in a wide range during the session, hitting a low of $0.54 and a high of $0.83 before settling near $0.65. This level of volatility and volume is highly unusual for the agri-food stock, which typically sees far less activity.

The price jump stands in stark contrast to the performance of larger food and ingredient companies. Ingredion slipped roughly 2%, Bunge Global gained about 3%, and Beyond Meat rose 2% by Monday afternoon. This divergence suggests that the move in Above Food shares was company-specific rather than sector-wide.

Filing Delays and Nasdaq Compliance

Above Food has yet to file its annual report for the fiscal year ended January 31, 2025. In an April 20 filing, the company disclosed that its independent auditor is still working on the consolidated financial statements. The delay is partly attributed to certain subsidiaries that have entered receivership beyond the company's control.

The company warned that it cannot guarantee when the fiscal 2025 results will be finalized or when its Form 20-F—the annual report required for foreign firms trading on U.S. exchanges—will be submitted. The April statement replaced earlier updates on the audit's progress and expected completion date.

In February, Above Food notified investors that Nasdaq had flagged the company for non-compliance with Listing Rule 5250(c)(2) due to the late filing of interim financials for the six months ended July 31, 2025. However, the company noted that the Nasdaq notice did not trigger any immediate consequences.

Financial Health and Business Segments

The stakes behind the delayed report are high given Above Food's recent financial performance. For fiscal 2024, the company reported revenue of $368.4 million but posted a net loss of $53.3 million. Cash on hand was just $1.0 million, and the company faced an $85.4 million working-capital deficit. Additionally, Above Food had breached covenants related to approximately $66 million in debt.

The company describes itself as an agricultural and food technology business focused on plant-based proteins, seed development, and the ingredient supply chain. Its operations are divided into two primary segments: "Disruptive Agriculture and Rudimentary Ingredients," which covers grain origination, grading, primary processing, and ingredient sales, and consumer packaged goods.

What's Next for ABVE

While Monday's rally caught the attention of traders, the key catalysts for the stock remain the completion of the audit, the filing of the Form 20-F, and the resolution of the overdue interim statements. Until those milestones are achieved, the company's listing on Nasdaq remains at risk, and investor uncertainty is likely to persist.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.